Printer Friendly

ST. JUDE MEDICAL ELECTS LEHMKUHL CHAIRMAN OF THE BOARD AND NAMES NEW PRESIDENT AND CHIEF EXECUTIVE OFFICER

 ST. PAUL, Minn., March 17 /PRNewswire/ -- St. Jude Medical, Inc., (NASDAQ-NMS: STJM) today announced the appointment of Lawrence A. Lehmkuhl, who has been president and chief executive officer of the company since February 1985, to the position of chairman of the board. Lehmkuhl is succeeding the company's current chairman, Dr. William G. Hendrickson. In honor of Hendrickson's significant contributions to the company as a director over the past 13 years and as chairman since October 1981, he will be named to the new position of chairman emeritus. Ronald A. Matricaria has been appointed by the board to succeed Lehmkuhl as president and chief executive officer. Matricaria will also become a member of St. Jude Medical's board of directors and will assume his new responsibilities on April 12, 1993.
 Matricaria comes to St. Jude Medical from Eli Lilly and Company, where he has held increasingly responsible executive management roles including his most recent post of executive vice president - Pharmaceutical Division and president - North American Operations. He had been employed by Eli Lilly since 1970 and his previous positions have included president - Lilly International, president - Medical Device Division and president and chief executive officer - Cardiac Pacemakers, Inc., a wholly-owned subsidiary of Eli Lilly.
 In announcing Matricaria's appointment, Lehmkuhl noted that he was the unanimous first choice of the board's search committee and cited his 27 years of health care industry experience. "Ron is a proven leader with an extensive medical device background and particular expertise in the cardiovascular area. He has demonstrated his abilities to grow businesses through a combination of internal development and external acquisition. His experience in this area will greatly benefit St. Jude Medical's growth strategy."
 Hendrickson commented on the strength of the company's leadership which has been and will continue to be of paramount importance in ensuring the company's continued profitable growth. "Larry Lehmkuhl has been an outstanding president and chief executive officer who took this company from a $26 million operation in 1985 to a highly successful business which is approaching a quarter billion dollars in sales with earnings in excess of a hundred million dollars. I believe he will be an equally outstanding chairman of the board. Ron Matricaria is a highly talented general manager with the necessary experience and skills to build on the strength of our core business and make St. Jude Medical a more diversified medical products company. Together Larry and Ron have over 50 years of health care experience and in combination with the company's senior executives represent the strongest management team in St. Jude Medical's history."
 Matricaria called his appointment an exciting opportunity. "St. Jude Medical's significant presence in the growth oriented cardiovascular segment of the medical device industry provides a solid foundation for further growth. I am looking forward to making a substantial contribution to St. Jude Medical's evolution into a major diversified medical products company."
 St. Jude Medical, Inc., a multi-national manufacturer and marketer of the world's most preferred mechanical heart valve with over 440,000 implantations since 1977, serves physicians worldwide with the highest quality products for cardiovascular care. The company posted record net sales of $240 million and record net income of $102 million in 1992.
 -0- 3/17/93
 /CONTACT: Paul Vetter, assistant treasurer, 612-481-7791; or Steve Wilson, V. P. finance & CFO, 6l2-48l-7542, both of St. Jude Medical/
 (STJM)


CO: St. Jude Medical, Inc. ST: Minnesota IN: MTC SU: PER

KH -- MN003 -- 7008 03/17/93 11:49 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 17, 1993
Words:573
Previous Article:PACIFIC SCIENTIFIC APPOINTS NEW DIVISION PRESIDENT
Next Article:BOSTON TECHNOLOGY ANNOUNCES RESULTS FOR FISCAL 1993
Topics:


Related Articles
ST. JUDE MEDICAL ANNOUNCES TWO SENIOR MANAGEMENT APPOINTMENTS
TOPOX TO CHANGE NAME
ADVANCED MEDICAL INC. MAKES MANAGEMENT CHANGES AND STEPS UP FOCUS ON IMED SUBSIDIARY
HENDRICKSON RETIRES FROM BOARD
WEGMILLER ELECTED CHAIRMAN AND DUTCHER ELECTED CEO OF POSSIS CORPORATION
WALTER L. SEMBROWICH, PH.D. JOINS ST. JUDE MEDICAL, INC. BOARD OF DIRECTORS
ST. JUDE MEDICAL ANNOUNCES EXECUTIVE APPOINTMENTS
RONALD A. MATRICARIA ELECTED CHAIRMAN, ST. JUDE MEDICAL BOARD OF DIRECTORS; DR. GAIL R. WILENSKY JOINS SJM BOARD
ST. JUDE MEDICAL ANNOUNCES PRESIDENT OF EUROPEAN OPERATIONS AND COUNTRY MANAGER FOR GERMANY
MEDICAL GRAPHICS CORPORATION ANNOUNCES NEW PRESIDENT/CEO & CHAIRMAN OF THE BOARD

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters